StockData
Aurinia Pharmaceuticals Inc. logo

Aurinia Pharmaceuticals Inc. (AUPH) stock

AUPHNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 13/3058% below fair value
$15.40−0.08 (-0.52%)

Close on Nov 17, 2026Market cap $2.06BP/E 6.7Yield –

Aurinia Pharmaceuticals enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Aurinia Pharmaceuticals's enterprise value was $1.97B on Nov 11, 2026, against $2.05B a year earlier. Over the last 5 years it ranged from $528.57M to $2.91B, with a median of $1.23B.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$1.97B-2.7%
2025Dec 31, 2025$2.03B+62.6%
2024Dec 31, 2024$1.25B+0.2%
2023Dec 29, 2023$1.25B+135.6%
2022Dec 30, 2022$528.57M-81.8%
2021Dec 31, 2021$2.91B+134.3%
2020Dec 31, 2020$1.24B-23.2%
2019Dec 31, 2019$1.61B+349.7%
2018Dec 31, 2018$358.95M+198.6%
2017Dec 29, 2017$120.19M–

More Aurinia Pharmaceuticals figures

See a number that looks wrong?